Discontinued ProductUnfortunately Burimamide oxalate (Cat. No. 1857) has been withdrawn from sale for commercial reasons.
Histamine H3/H2 receptor antagonist (Ki values are 0.07, 7.8 and 290 μM for H3, H2 and H1 receptors respectively). Displays partial agonist activity in SK-N-MC cells. Produces antinociceptive effects following intraventricular administration (ED50 = 183 nmol/mouse in hot-plate test).
|Storage||Desiccate at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Preparing Stock Solutions
The following data is based on the product molecular weight 302.35. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||3.31 mL||16.54 mL||33.07 mL|
|5 mM||0.66 mL||3.31 mL||6.61 mL|
|10 mM||0.33 mL||1.65 mL||3.31 mL|
|50 mM||0.07 mL||0.33 mL||0.66 mL|
The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.
References are publications that support the products' biological activity.
Lamberti et al (1996) Investigation into the role of histamine receptors in rodent antinociception. Pharmacol.Biochem.Behav. 53 567 PMID: 8866956
Hough et al (2000) Antinociceptive activity of derivatives of improgran and burimamide. Pharmacol.Biochem.Behav. 65 61 PMID: 10638637
View Related Products by Product Action
Keywords: Mixed H2/H3 antagonists H3 Receptors Histamine H2 histaminergic Histamine H2 Receptors
Citations for Burimamide oxalate
Citations are publications that use Tocris products.
Currently there are no citations for Burimamide oxalate.